These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24999026)
1. Low brain iron effects and reversibility on striatal dopamine dynamics. Unger EL; Bianco LE; Jones BC; Allen RP; Earley CJ Exp Neurol; 2014 Nov; 261():462-8. PubMed ID: 24999026 [TBL] [Abstract][Full Text] [Related]
2. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats. Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828 [TBL] [Abstract][Full Text] [Related]
3. Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Jellen LC; Lu L; Wang X; Unger EL; Earley CJ; Allen RP; Williams RW; Jones BC Neuroscience; 2013 Nov; 252():13-23. PubMed ID: 23911809 [TBL] [Abstract][Full Text] [Related]
4. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome. Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688 [TBL] [Abstract][Full Text] [Related]
5. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome. Allen RP; Earley CJ; Jones BC; Unger EL Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092 [TBL] [Abstract][Full Text] [Related]
6. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra. Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477 [TBL] [Abstract][Full Text] [Related]
7. Iron deficiency alters dopamine transporter functioning in rat striatum. Erikson KM; Jones BC; Beard JL J Nutr; 2000 Nov; 130(11):2831-7. PubMed ID: 11053528 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway. Andrés ME; Gysling K; Bustos G Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. Ferré S; Cortés R; Artigas F J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257 [TBL] [Abstract][Full Text] [Related]
11. Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degeneration. Sengstock GJ; Zawia NH; Olanow CW; Dunn AJ; Arendash GW Biol Trace Elem Res; 1997 Sep; 58(3):177-95. PubMed ID: 9403131 [TBL] [Abstract][Full Text] [Related]
12. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978 [TBL] [Abstract][Full Text] [Related]
13. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
14. 17β-Estradiol infusions into the dorsal striatum rapidly increase dorsal striatal dopamine release in vivo. Shams WM; Sanio C; Quinlan MG; Brake WG Neuroscience; 2016 Aug; 330():162-70. PubMed ID: 27256507 [TBL] [Abstract][Full Text] [Related]
15. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons. Moore H; Todd CL; Grace AA J Neurosci; 1998 Jul; 18(13):5068-77. PubMed ID: 9634572 [TBL] [Abstract][Full Text] [Related]
16. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065 [TBL] [Abstract][Full Text] [Related]
17. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach. Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009 [TBL] [Abstract][Full Text] [Related]
18. Effects of IV iron isomaltoside-1000 treatment on regional brain iron status in an iron-deficient animal. Unger EL; Earley CJ; Thomsen LL; Jones BC; Allen RP Neuroscience; 2013 Aug; 246():179-85. PubMed ID: 23660192 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254 [TBL] [Abstract][Full Text] [Related]
20. Striatal histamine mechanism in the pathogenesis of restless legs syndrome. Lai YY; Hsieh KC; Cheng YH; Chew KT; Nguyen D; Ramanathan L; Siegel JM Sleep; 2020 Feb; 43(2):. PubMed ID: 31671173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]